Tapewire

Nasdaq · USD

ELTX

Elicio Therapeutics, Inc.

Export transactions ↓
Tapewire entity
299
SEC CIK
0001601485
Parsed reports
140

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 28, 2024 Filed Jul 3, 2024 01:53 UTC PurchasePre-Funded Warrants · Derivative 50,000 $4.99 Strike: $0.01 $249,500.00
Disclosure

SEC source: 0001140361-24-032293 · form4.xml · derivative · entry 8

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F3 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.

F4 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date.

F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any.

Read SEC document
June 28, 2024 Filed Jul 3, 2024 01:53 UTC PurchaseCommon Warrants · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001140361-24-032293 · form4.xml · derivative · entry 7

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.

F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029.

F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any.

Read SEC document
June 28, 2024 Filed Jul 3, 2024 01:53 UTC PurchasePre-Funded Warrants · Derivative 50,000 $4.99 Strike: $0.01 $249,500.00
Disclosure

SEC source: 0001140361-24-032293 · form4.xml · derivative · entry 6

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F3 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.

F4 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date.

F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any.

Read SEC document
June 28, 2024 Filed Jul 3, 2024 01:53 UTC PurchaseCommon Warrants · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001140361-24-032293 · form4.xml · derivative · entry 5

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.

F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029.

F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any.

Read SEC document
June 28, 2024 Filed Jul 3, 2024 01:53 UTC PurchasePre-Funded Warrants · Derivative 50,000 $4.99 Strike: $0.01 $249,500.00
Disclosure

SEC source: 0001140361-24-032293 · form4.xml · derivative · entry 4

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F3 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.

F4 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date.

F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any.

Read SEC document
June 28, 2024 Filed Jul 3, 2024 01:53 UTC PurchaseCommon Warrants · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001140361-24-032293 · form4.xml · derivative · entry 3

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.

F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029.

F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any.

Read SEC document
June 28, 2024 Filed Jul 3, 2024 01:53 UTC PurchasePre-Funded Warrants · Derivative 50,000 $4.99 Strike: $0.01 $249,500.00
Disclosure

SEC source: 0001140361-24-032293 · form4.xml · derivative · entry 2

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F3 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.

F4 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date.

Read SEC document
June 28, 2024 Filed Jul 3, 2024 01:53 UTC PurchaseCommon Warrants · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001140361-24-032293 · form4.xml · derivative · entry 1

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.

F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 20:30 UTC
Chudnovsky YekaterinaDirector · 10% owner
GKCC, LLC10% owner
PurchasePre-Funded Warrants · Derivative 1,600,000 $4.99 Strike: $0.01 $7,984,000.00
Disclosure

SEC source: 0001140361-24-032163 · form4.xml · derivative · entry 2

Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner

GKCC, LLC · CIK 0001977769 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600,000

Underlying: Common Stock · 1,600,000 shares

Expires not disclosed

F3 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%.

F4 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 20:30 UTC
Chudnovsky YekaterinaDirector · 10% owner
GKCC, LLC10% owner
PurchaseCommon Warrants · Derivative 1,600,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001140361-24-032163 · form4.xml · derivative · entry 1

Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner

GKCC, LLC · CIK 0001977769 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600,000

Underlying: Common Stock · 1,600,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%.

F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029.

Read SEC document
June 28, 2024 Filed Jan 2, 2025 21:05 UTC Amendment PurchasePre-Funded Warrants · Derivative 50,000 $4.99 Strike: $0.01 $249,500.00
Disclosure

SEC source: 0001601485-25-000002 · wk-form4a_1735851944.xml · derivative · entry 2

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F4 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.

F5 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date.

F3 · ownership.direct: On July 2, 2024, the Reporting Person mistakenly filed a Form 4 reporting the acquisition of an additional 150,000 Common Warrants and 150,000 Pre-Funded Warrants. The Reporting Person is not the beneficial owner of such Common Warrants or Pre-Funded Warrants. As of January 2, 2025, the Reporting Person owned only the Common Warrants and Pre-Funded Warrants reported herein.

Read SEC document
June 28, 2024 Filed Jan 2, 2025 21:05 UTC Amendment PurchaseCommon Warrants · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001601485-25-000002 · wk-form4a_1735851944.xml · derivative · entry 1

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%.

F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029.

F3 · ownership.direct: On July 2, 2024, the Reporting Person mistakenly filed a Form 4 reporting the acquisition of an additional 150,000 Common Warrants and 150,000 Pre-Funded Warrants. The Reporting Person is not the beneficial owner of such Common Warrants or Pre-Funded Warrants. As of January 2, 2025, the Reporting Person owned only the Common Warrants and Pre-Funded Warrants reported herein.

Read SEC document
March 19, 2024 Filed Mar 20, 2024 20:28 UTC
Chudnovsky YekaterinaDirector · 10% owner
GKCC, LLC10% owner
PurchasePre-Funded Common Stock Purchase Warrant · Derivative 1,032,702 $5.81 Strike: $0.01 $5,999,998.62
Disclosure

SEC source: 0000950170-24-034198 · ownership.xml · derivative · entry 1

Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner

GKCC, LLC · CIK 0001977769 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by GKCC, LLC

Disclosed balance after: 1,032,702

Underlying: Common Stock · 1,032,702 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by GKCC, LLC at any time on or after March 19, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%, unless stockholder approval is obtained.

F2 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date.

F3 · ownership.nature: Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 11:01 UTC
Piekos BrianChief Financial Officer
GrantStock Option (right to buy) · Derivative 43,225 $0.00 Strike: $4.50 $0.00
Disclosure

SEC source: 0001140361-24-005499 · form4.xml · derivative · entry 1

Piekos Brian · CIK 0001815308 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,225

Underlying: Common Stock · 43,225 shares

Expires 2034-02-01

F1 · derivative.exercise_date: Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 11:01 UTC
Haqq ChristopherSee Remarks
GrantStock Option (right to buy) · Derivative 28,200 $0.00 Strike: $4.50 $0.00
Disclosure

SEC source: 0001140361-24-005497 · form4.xml · derivative · entry 1

Haqq Christopher · CIK 0001612095 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,200

Underlying: Common Stock · 28,200 shares

Expires 2034-02-01

F1 · derivative.exercise_date: Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 11:01 UTC
Connelly RobertDirector · CEO, President and Director
GrantStock Option (right to buy) · Derivative 225,137 $0.00 Strike: $4.50 $0.00
Disclosure

SEC source: 0001140361-24-005498 · form4.xml · derivative · entry 1

Connelly Robert · CIK 0001796436 · Director · CEO, President and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,137

Underlying: Common Stock · 225,137 shares

Expires 2034-02-01

F1 · derivative.exercise_date: Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 11:01 UTC
DeMuth PeterChief Scientific Officer
GrantStock Option (right to buy) · Derivative 342 $0.00 Strike: $4.50 $0.00
Disclosure

SEC source: 0001140361-24-005496 · form4.xml · derivative · entry 2

DeMuth Peter · CIK 0001979163 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 342

Underlying: Common Stock · 342 shares

Expires 2034-02-01

F2 · derivative.exercise_date: The stock options vested in full on February 1, 2024.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 11:01 UTC
DeMuth PeterChief Scientific Officer
GrantStock Option (right to buy) · Derivative 29,800 $0.00 Strike: $4.50 $0.00
Disclosure

SEC source: 0001140361-24-005496 · form4.xml · derivative · entry 1

DeMuth Peter · CIK 0001979163 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,800

Underlying: Common Stock · 29,800 shares

Expires 2034-02-01

F1 · derivative.exercise_date: Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 17:05 UTC GrantStock Option (right to buy) · Derivative 4,100 $0.00 Strike: $8.26 $0.00
Disclosure

SEC source: 0001140361-23-060236 · form4.xml · derivative · entry 1

Ashe Carol Gail · CIK 0001761748 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,100

Underlying: Common Stock · 4,100 shares

Expires 2033-12-28

F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 22:05 UTC GrantStock Option (right to buy) · Derivative 4,100 $0.00 Strike: $8.26 $0.00
Disclosure

SEC source: 0001140361-23-060239 · form4.xml · derivative · entry 1

Nissenson Allen · CIK 0001441889 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,100

Underlying: Common Stock · 4,100 shares

Expires 2033-12-28

F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 22:05 UTC GrantStock Option (right to buy) · Derivative 4,100 $0.00 Strike: $8.26 $0.00
Disclosure

SEC source: 0001140361-23-060235 · form4.xml · derivative · entry 1

Venkatesan Jay · CIK 0001413350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,100

Underlying: Common Stock · 4,100 shares

Expires 2033-12-28

F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 22:05 UTC GrantStock Option (right to buy) · Derivative 4,100 $0.00 Strike: $8.26 $0.00
Disclosure

SEC source: 0001140361-23-060237 · form4.xml · derivative · entry 1

WILSON KAREN J · CIK 0001267490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,100

Underlying: Common Stock · 4,100 shares

Expires 2033-12-28

F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 22:05 UTC GrantStock Option (right to buy) · Derivative 4,100 $0.00 Strike: $8.26 $0.00
Disclosure

SEC source: 0001140361-23-060233 · form4.xml · derivative · entry 1

RUFFOLO ROBERT R · CIK 0001187308 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,100

Underlying: Common Stock · 4,100 shares

Expires 2033-12-28

F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 17:05 UTC
ADAMS JULIANDirector
GrantStock Option (right to buy) · Derivative 4,100 $0.00 Strike: $8.26 $0.00
Disclosure

SEC source: 0001140361-23-060234 · form4.xml · derivative · entry 1

ADAMS JULIAN · CIK 0001230486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,100

Underlying: Common Stock · 4,100 shares

Expires 2033-12-28

F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 22:05 UTC
Chudnovsky YekaterinaDirector · 10% owner
GrantStock Option (right to buy) · Derivative 4,100 $0.00 Strike: $8.26 $0.00
Disclosure

SEC source: 0001140361-23-060238 · form4.xml · derivative · entry 1

Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,100

Underlying: Common Stock · 4,100 shares

Expires 2033-12-28

F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

Read SEC document
December 22, 2023 Filed Dec 26, 2023 21:29 UTC
Chudnovsky YekaterinaDirector · 10% owner
GKCC, LLC10% owner
PurchaseCommon Stock 1,213,000 $5.81 $7,047,530.00
Disclosure

SEC source: 0001209191-23-059683 · doc4.xml · nonDerivative · entry 1

Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner

GKCC, LLC · CIK 0001977769 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by GKCC, LLC

Disclosed balance after: 1,915,639

F1 · ownership.nature: Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 21:25 UTC
Piekos BrianChief Financial Officer
GrantStock Option (right to buy) · Derivative 75,484 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001140361-23-028420 · form4.xml · derivative · entry 1

Piekos Brian · CIK 0001815308 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,484

Underlying: Common Stock · 75,484 shares

Expires 2033-06-01

F1 · derivative.exercise_date: The option vests as to 25% of the option shares on May 15, 2024 with the remainder vesting in 36 equal monthly installments at the end of each month thereafter, subject to the Reporting Person continuing to provide services to the Issuer through the applicable vesting dates, and provided that in the event there is a change in control of the Issuer, followed by a subsequent termination of the Reporting Person's employment without cause (or a material diminishment of his role) within 12 months of the change of control, any unvested options granted will immediately vest.

Read SEC document
July 01, 2022 Filed Jul 11, 2022 19:54 UTC Tax withholdingCommon Stock 32,082 $1.12 $35,931.84
Disclosure

SEC source: 0001601485-22-000059 · wf-form4_165758365151556.xml · nonDerivative · entry 1

Goldberg Itzhak · CIK 0001607858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,687,986

F1 · kind: The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs").

Read SEC document
June 09, 2022 Filed Jun 13, 2022 21:26 UTC GrantCommon Stock · Derivative 15,000 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001601485-22-000052 · wf-form4_165515558808558.xml · derivative · entry 1

Nissenson Allen · CIK 0001441889 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-09

F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 09, 2022 Filed Jun 13, 2022 21:26 UTC GrantCommon Stock · Derivative 15,000 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001601485-22-000051 · wf-form4_165515557133787.xml · derivative · entry 1

WILSON KAREN J · CIK 0001267490 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-09

F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 09, 2022 Filed Jun 13, 2022 21:26 UTC GrantCommon Stock · Derivative 15,000 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001601485-22-000050 · wf-form4_165515555115849.xml · derivative · entry 1

OMENN GILBERT S · CIK 0001184227 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-09

F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 09, 2022 Filed Jun 13, 2022 17:27 UTC GrantCommon Stock · Derivative 15,000 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001601485-22-000053 · wf-form4_165515561728971.xml · derivative · entry 1

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-09

F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
May 25, 2022 Filed May 27, 2022 20:18 UTC
Venkatesan JayDirector · See Remarks
PurchaseCommon Stock 11,313 $1.25 $14,102.79
Disclosure

SEC source: 0001601485-22-000043 · wf-form4_165368268236817.xml · nonDerivative · entry 1

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,891,947

Read SEC document
May 24, 2022 Filed May 25, 2022 21:58 UTC
Venkatesan JayDirector · See Remarks
PurchaseCommon Stock 32,200 $1.24 $39,928.00
Disclosure

SEC source: 0001601485-22-000039 · wf-form4_165351588830337.xml · nonDerivative · entry 2

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,721,457

Read SEC document
May 20, 2022 Filed May 23, 2022 23:48 UTC PurchaseCommon Stock 2,037 $1.18 $2,403.66
Disclosure

SEC source: 0001628280-22-015238 · wf-form4_165334970201347.xml · nonDerivative · entry 2

Nissenson Allen · CIK 0001441889 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,383

Read SEC document
May 20, 2022 Filed May 25, 2022 21:58 UTC
Venkatesan JayDirector · See Remarks
PurchaseCommon Stock 50,000 $1.23 $61,500.00
Disclosure

SEC source: 0001601485-22-000039 · wf-form4_165351588830337.xml · nonDerivative · entry 1

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,689,257

Read SEC document
May 19, 2022 Filed May 23, 2022 23:48 UTC PurchaseCommon Stock 7,346 $1.16 $8,521.36
Disclosure

SEC source: 0001628280-22-015238 · wf-form4_165334970201347.xml · nonDerivative · entry 1

Nissenson Allen · CIK 0001441889 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,346

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.18 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:22 UTC
Venkatesan JaySee Remarks
GrantStock Option (Right to Buy) · Derivative 160,000 $0.00 Strike: $1.94 $0.00
Disclosure

SEC source: 0001601485-22-000014 · wf-form4_164642894442998.xml · derivative · entry 2

Venkatesan Jay · CIK 0001413350 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 760,000

Underlying: Common Stock · 160,000 shares

Expires 2032-03-02

F2 · derivative.exercise_date: The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022.

Read SEC document
March 03, 2022 Filed Mar 4, 2022 21:22 UTC
Venkatesan JaySee Remarks
GrantStock Option (Right to Buy) · Derivative 600,000 $0.00 Strike: $1.94 $0.00
Disclosure

SEC source: 0001601485-22-000014 · wf-form4_164642894442998.xml · derivative · entry 1

Venkatesan Jay · CIK 0001413350 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2032-03-02

F1 · derivative.exercise_date: The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 16:21 UTC
Neylan John F.See Remarks
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $1.99 $0.00
Disclosure

SEC source: 0001601485-22-000013 · wf-form4_164642889806390.xml · derivative · entry 2

Neylan John F. · CIK 0001640447 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,000

Underlying: Common Stock · 100,000 shares

Expires 2032-03-01

F2 · derivative.exercise_date: The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 16:21 UTC
Neylan John F.See Remarks
GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $1.99 $0.00
Disclosure

SEC source: 0001601485-22-000013 · wf-form4_164642889806390.xml · derivative · entry 1

Neylan John F. · CIK 0001640447 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2032-03-01

F1 · derivative.exercise_date: The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 21:20 UTC
CURHAN GREGORY SSee Remarks
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $1.99 $0.00
Disclosure

SEC source: 0001601485-22-000011 · wf-form4_164642880552681.xml · derivative · entry 1

CURHAN GREGORY S · CIK 0001263244 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-03-01

F1 · derivative.exercise_date: The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 16:21 UTC GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $1.99 $0.00
Disclosure

SEC source: 0001601485-22-000012 · wf-form4_164642885246988.xml · derivative · entry 2

Rhodes Jennifer J · CIK 0001568249 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,000

Underlying: Common Stock · 100,000 shares

Expires 2032-03-01

F2 · derivative.exercise_date: The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 16:21 UTC GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $1.99 $0.00
Disclosure

SEC source: 0001601485-22-000012 · wf-form4_164642885246988.xml · derivative · entry 1

Rhodes Jennifer J · CIK 0001568249 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2032-03-01

F1 · derivative.exercise_date: The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
December 28, 2021 Filed Dec 29, 2021 21:08 UTC
Venkatesan JayDirector · See Remarks
PurchaseCommon Stock 210,337 $2.66 $559,853.99
Disclosure

SEC source: 0001601485-21-000095 · wf-form4_164081206871822.xml · nonDerivative · entry 2

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,639,257

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.75 inclusive.

Read SEC document
December 27, 2021 Filed Dec 29, 2021 21:08 UTC
Venkatesan JayDirector · See Remarks
PurchaseCommon Stock 66,907 $2.55 $170,519.18
Disclosure

SEC source: 0001601485-21-000095 · wf-form4_164081206871822.xml · nonDerivative · entry 1

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,428,920

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.55 inclusive.

Read SEC document
December 20, 2021 Filed Dec 21, 2021 16:25 UTC
Neylan John F.See Remarks
SaleCommon Stock 358 $2.62 $938.00
Disclosure

SEC source: 0001601485-21-000091 · wf-form4_164012191372345.xml · nonDerivative · entry 1

Neylan John F. · CIK 0001640447 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,136

F1 · kind: The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted on March 18, 2021 by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 21:06 UTC
Venkatesan JayDirector · See Remarks
PurchaseCommon Stock 3,527 $2.54 $8,975.86
Disclosure

SEC source: 0001601485-21-000093 · wf-form4_164020718382276.xml · nonDerivative · entry 1

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,362,013

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.52 to $2.55 inclusive.

Read SEC document
December 17, 2021 Filed Dec 20, 2021 23:44 UTC
Venkatesan JayDirector · See Remarks
PurchaseCommon Stock 13,742 $2.54 $34,958.27
Disclosure

SEC source: 0001601485-21-000089 · wf-form4_164004385539278.xml · nonDerivative · entry 2

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,358,486

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.55 inclusive.

Read SEC document
December 16, 2021 Filed Dec 20, 2021 23:44 UTC
Venkatesan JayDirector · See Remarks
PurchaseCommon Stock 27,883 $2.55 $70,992.91
Disclosure

SEC source: 0001601485-21-000089 · wf-form4_164004385539278.xml · nonDerivative · entry 1

Venkatesan Jay · CIK 0001413350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,344,744

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.55 inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.